Voltammetric Determination of Hydroxychloroquine Used in the Treatment of COVID‐19 at MWCNT Modified Pencil Graphite Electrode
Öz
Anahtar Kelimeler
Kaynakça
- [1]. WHO, WHO Director-General's opening remarks at the media briefing on COVID-19. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020/, 11 Mach 2020 (accessed at 23.05.2025).
- [2]. WHO, WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/, 9 November 2022 (accessed at 23.05.2025).
- [3]. Stasi, C, Fallani, S, Voller, F, Silvestri, C. 2020. Treatment for COVID-19: An overview. European Journal of Pharmacology; 889: 173644.
- [4]. Sinha, N, Balayla, G. 2020. Hydroxychloroquine and COVID-19. Postgraduate Medical Journal; 96: 550–555.
- [5]. Fox, RI. 1993. Mechanism of action of hydroxychloroquine as an antirheumatic drug. Seminars in Arthritis and Rheumatism; 23(2): 82-91.
- [6]. Ferner, RE, Aronson, JK. 2020. Chloroquine and hydroxychloroquine in COVID-19. BMJ; 369: m1432.
- [7]. The RECOVERY Collaborative Group. 2020. Effect of hydroxychloroquine in hospitalized patients with COVID-19. The New England Journal of Medicine; 383(21): 2030-2040.
- [8]. WHO, WHO solidarity trial consortium, repurposed antiviral drugs for COVID-19 — interim who solidarity trial results. 2021. The New England Journal of Medicine; 384(6): 497-511.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Elektrokimya
Bölüm
Araştırma Makalesi
Yazarlar
Şevval Sazlık
0009-0006-1052-4184
Türkiye
İrem Demir
0009-0002-7687-927X
Türkiye
Selen Ayaz
0000-0003-0320-3551
Türkiye
Yayımlanma Tarihi
26 Eylül 2025
Gönderilme Tarihi
26 Mayıs 2025
Kabul Tarihi
19 Temmuz 2025
Yayımlandığı Sayı
Yıl 2025 Cilt: 21 Sayı: 3